Adverse events of tissue plasminogen activators in acute myocardial infarction patients: a real-world and pharmacovigilance database analysis
Article in BMC Cardiovascular Disorders (August 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Toxicity burden patterns of MET-selective tyrosine kinase inhibitors: evidence from real-world pharmacovigilance
Article in Investigational New Drugs (May 2024)
A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors
Article in Annals of Hematology (March 2024)